Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Tau alternative splicing in familial and sporadic tauopathies.

Niblock M, Gallo JM.

Biochem Soc Trans. 2012 Aug;40(4):677-80. doi: 10.1042/BST20120091. Review.

PMID:
22817715
2.

Regulation of alternative splicing of tau exon 10.

Qian W, Liu F.

Neurosci Bull. 2014 Apr;30(2):367-77. doi: 10.1007/s12264-013-1411-2. Epub 2014 Mar 14. Review.

3.

Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.

Zhou J, Yu Q, Zou T.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S10. doi: 10.1186/1471-2202-9-S2-S10. Review.

4.

An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.

Wang Y, Wang J, Gao L, Stamm S, Andreadis A.

Gene. 2011 Oct 10;485(2):130-8. doi: 10.1016/j.gene.2011.06.020. Epub 2011 Jun 30.

5.

Quantitative analysis of tau isoform transcripts in sporadic tauopathies.

Connell JW, Rodriguez-Martin T, Gibb GM, Kahn NM, Grierson AJ, Hanger DP, Revesz T, Lantos PL, Anderton BH, Gallo JM.

Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):104-9. Epub 2005 Mar 29.

PMID:
15950767
6.

Tau protein in familial and sporadic diseases.

Yancopoulou D, Spillantini MG.

Neuromolecular Med. 2003;4(1-2):37-48. Review.

PMID:
14528051
7.

Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.

Gu J, Chen F, Iqbal K, Gong CX, Wang X, Liu F.

J Biol Chem. 2017 Jun 23;292(25):10600-10612. doi: 10.1074/jbc.M117.783498. Epub 2017 May 9.

PMID:
28487370
8.
9.

Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing.

Rodriguez-Martin T, Anthony K, Garcia-Blanco MA, Mansfield SG, Anderton BH, Gallo JM.

Hum Mol Genet. 2009 Sep 1;18(17):3266-73. doi: 10.1093/hmg/ddp264. Epub 2009 Jun 4.

10.

Abeta(1-42) induces abnormal alternative splicing of tau exons 2/3 in NGF-induced PC12 cells.

Lagunes T, Herrera-Rivero M, Hernández-Aguilar ME, Aranda-Abreu GE.

An Acad Bras Cienc. 2014 Dec;86(4):1927-34. doi: 10.1590/0001-3765201420130333. Epub 2014 Nov 28.

11.

Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.

Rodriguez-Martin T, Garcia-Blanco MA, Mansfield SG, Grover AC, Hutton M, Yu Q, Zhou J, Anderton BH, Gallo JM.

Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15659-64. Epub 2005 Oct 17.

12.

Frontotemporal dementia with tau pathology.

Gasparini L, Terni B, Spillantini MG.

Neurodegener Dis. 2007;4(2-3):236-53. Review.

PMID:
17596718
13.

Disentangling the role of the tau gene locus in sporadic tauopathies.

Vandrovcova J, Anaya F, Kay V, Lees A, Hardy J, de Silva R.

Curr Alzheimer Res. 2010 Dec;7(8):726-34. Review.

PMID:
20704554
14.

RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies.

Gallo JM, Noble W, Martin TR.

Cell Mol Life Sci. 2007 Jul;64(13):1701-14. Review.

PMID:
17453144
15.

Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.

Lisowiec J, Magner D, Kierzek E, Lenartowicz E, Kierzek R.

RNA Biol. 2015;12(3):330-42. doi: 10.1080/15476286.2015.1017214.

16.

Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.

Iovino M, Agathou S, González-Rueda A, Del Castillo Velasco-Herrera M, Borroni B, Alberici A, Lynch T, O'Dowd S, Geti I, Gaffney D, Vallier L, Paulsen O, Káradóttir RT, Spillantini MG.

Brain. 2015 Nov;138(Pt 11):3345-59. doi: 10.1093/brain/awv222. Epub 2015 Jul 27.

17.

Mutations in the tau gene (MAPT) in FTDP-17: the family with Multiple System Tauopathy with Presenile Dementia (MSTD).

Spillantini MG, Murrell JR, Goedert M, Farlow M, Klug A, Ghetti B.

J Alzheimers Dis. 2006;9(3 Suppl):373-80.

PMID:
16914875
18.

Untangling the tau gene association with neurodegenerative disorders.

Pittman AM, Fung HC, de Silva R.

Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R188-95. Review.

PMID:
16987883
19.

The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.

Glatz DC, Rujescu D, Tang Y, Berendt FJ, Hartmann AM, Faltraco F, Rosenberg C, Hulette C, Jellinger K, Hampel H, Riederer P, Möller HJ, Andreadis A, Henkel K, Stamm S.

J Neurochem. 2006 Feb;96(3):635-44. Epub 2005 Dec 20.

20.

MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies.

Trabzuni D, Wray S, Vandrovcova J, Ramasamy A, Walker R, Smith C, Luk C, Gibbs JR, Dillman A, Hernandez DG, Arepalli S, Singleton AB, Cookson MR, Pittman AM, de Silva R, Weale ME, Hardy J, Ryten M.

Hum Mol Genet. 2012 Sep 15;21(18):4094-103. doi: 10.1093/hmg/dds238. Epub 2012 Jun 20.

Supplemental Content

Support Center